PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.34%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-27.70%
Negative gross profit growth while STERV.HE is at 3.45%. Joel Greenblatt would examine cost competitiveness or demand decline.
-44.39%
Negative EBIT growth while STERV.HE is at 37.96%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-44.39%
Negative operating income growth while STERV.HE is at 37.96%. Joel Greenblatt would press for urgent turnaround measures.
-35.91%
Negative net income growth while STERV.HE stands at 57.53%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-36.36%
Negative EPS growth while STERV.HE is at 57.45%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-36.36%
Negative diluted EPS growth while STERV.HE is at 57.45%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.28%
Share reduction while STERV.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.43%
Reduced diluted shares while STERV.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
5.72%
Positive OCF growth while STERV.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-152.97%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
2.28%
10Y revenue/share CAGR under 50% of STERV.HE's 5.03%. Michael Burry would suspect a lasting competitive disadvantage.
33.94%
5Y revenue/share CAGR above 1.5x STERV.HE's 14.07%. David Dodd would look for consistent product or market expansions fueling outperformance.
14.59%
3Y revenue/share CAGR at 75-90% of STERV.HE's 18.80%. Bill Ackman would expect new product strategies to close the gap.
293.42%
Positive long-term OCF/share growth while STERV.HE is negative. John Neff would see a structural advantage in sustained cash generation.
-33.32%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-28.40%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
63.39%
Net income/share CAGR at 50-75% of STERV.HE's 123.85%. Martin Whitman might question if the firm’s product or cost base lags behind.
80.25%
Below 50% of STERV.HE's 236.81%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
324.81%
3Y net income/share CAGR above 1.5x STERV.HE's 12.70%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
109.80%
10Y equity/share CAGR in line with STERV.HE's 116.66%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
79.73%
5Y equity/share CAGR at 50-75% of STERV.HE's 108.60%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
42.21%
3Y equity/share CAGR at 50-75% of STERV.HE's 68.70%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.44%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.38%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.21%
Asset growth above 1.5x STERV.HE's 0.20%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.24%
BV/share growth above 1.5x STERV.HE's 0.34%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-2.52%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
33.58%
We expand SG&A while STERV.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.